维普中文期刊产品整合服务
43篇 您的检索式:作者名="Lillicrap"
    题名 作者 年代 出处 被引量
1Muhiyear therapeutic benefit of AAV serotypes 2,6 ,and 8 delivering factor Ⅷ to hemophilia A mice and dogs 显示文摘Jiang H Lillicrap D Patarroyo-White S 2006Blood2006,108,1:1
2Dangerous liaisons: the role of 'danger' signals in the immune response to gene therapy显示文摘B D Brown D Lillicrap 2002Blood2002,100,4:1
3Molecular diagnosis of inherited bleeding disorders and thrombophilia显示文摘 1999Sem Hematol1999,36,:1
4Bioconcentration of the intense sweetener sucralose in a multitrophic battery of aquatic organisms 显示文摘Lillicrap A Langford K Tollefsen K E 2011Environ Toxicol Chem2011,30,3:1
5X-ray spectra from accelerators in the range 2 to 6 MeV显示文摘BENTLEY R E JONES J C LILLICRAP S C 1967Phys Med Biol1967,12,:1
6Efficacy and safety of a new-class of hemostatic drug candidate,AV513,in hemophilia A dogs显示文摘PRASAD S LILLICRAP D LABELLE A 2008Blood2008,111,:1
7Defming the chronic impacts of atenolol on embryo - larval de?velopment and reproduction in the fathead minnow (Pimephales promelas)显示文摘Winter MJ Lillicrap A D CaunterJ E 2008Aquatic Toxicology2008,86,3:1
8Multi -year therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs 显示文摘Jiang H Lillicrap D Patarroyo-White S 2006Blood2006,108,1:1
9Recombinant factor Ⅸ recovery and inhibitor safety: a Canadian post-licensure surveillance study 显示文摘Poon MC Lillicrap D Hensman C 2002Thromb Haemost2002,87,3:1
10The molecular basis of haemophilia B 显示文摘Lillicrap D 1998Haemophilia ttaemophilia1998,4,4:1
11Extending half-life in coagulation factors:where do we stand显示文摘Lillicrap D 0,,04:1
12Can activated recombinant factor Ⅶ be used to postpone the exposure of infants to factor Ⅷ until after 2 years of age? 显示文摘Rivard GE Lillicrap D Poon MC 2005Haemophilia2005,11,4:1
13Finite Element Modeling of Optic Chiasmal Compression显示文摘Xiaofei Wang Andrew J. Neely Gawn G. McIlwaine Murat Tahtali Thomas P. Lillicrap Christian J. Lueck 2014Journal of Neuro-Ophthalmology2014,,4:1
14Muhiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs显示文摘Jiang H Lillicrap D Patarroyo-White S 2006Blood2006,108,1:1
15Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations显示文摘 O'Brien LA Lillicrap D 2004J Mol Model (Online)2004,10,4:1
16Dangerous liaisons: the role of 'danger' signals in the immune response to gene therapy 显示文摘BrownD Lillicrap D 2002Blood2002,100,4:1
17PCR-构象敏感凝胶电泳技术在血友病A基因分型诊断及携带者检测中的应用显示文摘目的建立一种简便、快速的血友病A(hemophilia A,HA)基因突变筛查方法学,并用于直接基因诊断及携带者筛查。方法对于临床确诊的24例血友病A患者和家系女性成员,首先采用倒位PCR及PCR技术,检测是否为F脚基因第22、1内含子倒位或倒位携带者;对非倒位者则用PCR扩增FⅧ基因26个外显子,继而应用构象敏感凝胶电泳(conformation sensitive gel electrophoresis,CSGE)技术对37个扩增片段进行突变筛查,阳性者予以进一步测序验证;据突变类型,对非倒位HA先证者家系女性成员直接测序或行CSGE检测,以判读其是否为携带者。结果24个HA家系中,7例先证者FⅧ基因第22内含子倒位检测为阳性,未发现第1内含子倒位;13个有家族史及3个散发非倒位HA家系中均存在FⅧ基因不同外显子区的单碱基突变,1例未检出突变。本研究中,24个家系中基因分型诊断及携带者筛查阳性率、可诊断率分别为94.12%(16/17),100%(17/17)。结论PCR—CSGE检测HA单碱基突变高度敏感、特异;F脚基因第22、1内含子检测联合PCR—CSGE基因分型诊断技术及核苷酸测序可对所有的HA家系(含散发)进行直接基因诊断,理论上可筛查新突变并明确其突变类型。该法简便、快速、成本低,在HA直接基因诊断及携带者筛查中优势独特,应具重要应用价值。David Lillicrap 何国平 Jayne Leggo 刘雨生 童先宏 周桂香 骆丽华 2009中华医学遗传学杂志2009,26,4:1
18Bioconcentration of the intense sweetener sucmlose in a multitrophic battery of aquatic organisms显示文摘LILLICRAP A LANGFORD K TOLLEFSEN K E 2011Environmental Toxicology and Chemistry2011,30,3:1
19The molecular mechanisms of immuno modulation and tolerance induction to factor Ⅷ显示文摘Waters B Lillicrap D 2009J Thromb Haemost2009,7,14:1
20Hemophilia gene therapy:it's a matter of expression显示文摘Lillicrap D 2004Blood2004,103,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费